WO2008068778A3 - Extended release pharmaceutical composition of pramipexole - Google Patents

Extended release pharmaceutical composition of pramipexole Download PDF

Info

Publication number
WO2008068778A3
WO2008068778A3 PCT/IN2007/000586 IN2007000586W WO2008068778A3 WO 2008068778 A3 WO2008068778 A3 WO 2008068778A3 IN 2007000586 W IN2007000586 W IN 2007000586W WO 2008068778 A3 WO2008068778 A3 WO 2008068778A3
Authority
WO
WIPO (PCT)
Prior art keywords
pramipexole
extended release
pharmaceutical composition
release pharmaceutical
composition
Prior art date
Application number
PCT/IN2007/000586
Other languages
French (fr)
Other versions
WO2008068778A8 (en
WO2008068778A2 (en
Inventor
Rajesh Kshirsagar
Ashwin Rao
Nilesh Malaviya
Original Assignee
Alembic Ltd
Rajesh Kshirsagar
Ashwin Rao
Nilesh Malaviya
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alembic Ltd, Rajesh Kshirsagar, Ashwin Rao, Nilesh Malaviya filed Critical Alembic Ltd
Publication of WO2008068778A2 publication Critical patent/WO2008068778A2/en
Publication of WO2008068778A8 publication Critical patent/WO2008068778A8/en
Publication of WO2008068778A3 publication Critical patent/WO2008068778A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/428—Thiazoles condensed with carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

An extended release pharmaceutical composition comprising pramipexole having an extended release profile such that not less than 25% of the total amount of pramipexole or a pharmaceutically acceptable salt thereof in the composition is released within one hour no, significant release of the drug takes place over the subsequent one hour and not less than 80% of the total amount of pramipexole or a pharmaceutically acceptable salt thereof in the composition is released over a period of about 24 hours.
PCT/IN2007/000586 2006-12-05 2007-12-05 Extended release pharmaceutical composition of pramipexole WO2008068778A2 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
IN2000MU2006 2006-12-05
IN2000/MUM/2006 2006-12-05
IN2129MU2006 2006-12-26
IN2129/MUM/2006 2006-12-26

Publications (3)

Publication Number Publication Date
WO2008068778A2 WO2008068778A2 (en) 2008-06-12
WO2008068778A8 WO2008068778A8 (en) 2009-04-30
WO2008068778A3 true WO2008068778A3 (en) 2009-06-11

Family

ID=39301321

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IN2007/000586 WO2008068778A2 (en) 2006-12-05 2007-12-05 Extended release pharmaceutical composition of pramipexole

Country Status (1)

Country Link
WO (1) WO2008068778A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102665696A (en) * 2009-12-16 2012-09-12 巴斯夫欧洲公司 Film coating agents based on combinations of polyvinyl alcohol-polyether graft polymers and polyvinyl alcohol, having an improved moisture barrier effect
WO2011128914A2 (en) 2010-04-15 2011-10-20 Cadila Healthcare Limited Extended release pharmaceutical compositions of pramipexole
WO2011148243A1 (en) 2010-05-24 2011-12-01 Lupin Limited Extended release formulation of pramipexole
KR101307334B1 (en) 2010-07-02 2013-09-12 주식회사 바이오파마티스 Sustained-release pharmaceutical composition comprising pramipexole or pharmaceutically acceptable salt thereof having improved stability

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030077297A1 (en) * 1999-02-26 2003-04-24 Feng-Jing Chen Pharmaceutical formulations and systems for improved absorption and multistage release of active agents
US20030152627A1 (en) * 2001-01-31 2003-08-14 Thomas Beckert Multi-particulate form of medicament, comprising at least two differently coated forms of pellet
WO2004087175A1 (en) * 2003-04-04 2004-10-14 Pharmacia Corporation Oral extended release compressed tablets of multiparticulates
WO2005014562A1 (en) * 2003-07-25 2005-02-17 Synthon B.V. Pramipexole acid addition salts
WO2006035416A2 (en) * 2004-09-27 2006-04-06 Sigmoid Biotechnologies Limited Minicapsule formulations
WO2006102964A2 (en) * 2005-03-29 2006-10-05 Evonik Röhm Gmbh Multiparticulate pharmaceutical form comprising pellets with a substance having a modular effect in relation to active ingredient release

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030077297A1 (en) * 1999-02-26 2003-04-24 Feng-Jing Chen Pharmaceutical formulations and systems for improved absorption and multistage release of active agents
US20030152627A1 (en) * 2001-01-31 2003-08-14 Thomas Beckert Multi-particulate form of medicament, comprising at least two differently coated forms of pellet
WO2004087175A1 (en) * 2003-04-04 2004-10-14 Pharmacia Corporation Oral extended release compressed tablets of multiparticulates
WO2005014562A1 (en) * 2003-07-25 2005-02-17 Synthon B.V. Pramipexole acid addition salts
WO2006035416A2 (en) * 2004-09-27 2006-04-06 Sigmoid Biotechnologies Limited Minicapsule formulations
WO2006102964A2 (en) * 2005-03-29 2006-10-05 Evonik Röhm Gmbh Multiparticulate pharmaceutical form comprising pellets with a substance having a modular effect in relation to active ingredient release

Also Published As

Publication number Publication date
WO2008068778A8 (en) 2009-04-30
WO2008068778A2 (en) 2008-06-12

Similar Documents

Publication Publication Date Title
WO2011084593A3 (en) Abuse-resistant formulations
WO2006128022A3 (en) Solid compositions and methods for treating middle-of-the night insomnia
WO2007048219A3 (en) Sustained drug release composition
IL164302A (en) Substituted benzazoles, compositions and use thereof in the manufacture of a medicament for the inhibition of raf kinase activity
WO2008084698A1 (en) Tacrolimus sustained release pharmaceutical composition
HK1152055A1 (en) Hyaluronic acid derivative and drug containing the same
WO2007087452A3 (en) Abuse resistant and extended release formulations and method of use thereof
WO2009045795A3 (en) Galenical formulations of aliskiren and valsartan
PL1736160T3 (en) Algin oligosaccharides and the derivatives thereof as well as the manufacture and the use of the same
AU2005339139A8 (en) Pharmaceutical compositions and methods for treating or preventing oxalate-related disease
PT2205279E (en) Pharmaceutical combination of aliskiren and valsartan
EP2137175A4 (en) Novel phenanthrenequinone-based compound and pharmaceutical composition containing the same for the treatment or prevention of disease involving metabolic syndrome
IL201730A (en) Derivatives of 1h-benzoimidazol-2-yl-propyl-methyl-amino-ethyl-5-aryl-bicyclo[2.2.2]oct-5-en-2-ol, pharmaceutical compositions comprising them and their use in the manufacture of medicaments
WO2009068708A8 (en) Pharmaceutical composition with prolonged release of somatostatin or an analogue thereof
EP2042494A4 (en) 2,4,5-trisubstituted thiazole compounds,preparation methods, pharmaceutical compositions and medical uses thereof
ZA201003794B (en) Novel 1,3-dihydro-5-isobenzofurancarbonitrile derivatives and pharmaceutical composition thereof for the treatment of premature ejaculation
IL194880A (en) Aminothiazole derivatives, their use in the treatment of diseases and pharmaceutical compositions comprising them
WO2008081829A1 (en) Aminoalkylmethacrylate copolymer e for maintaining solubility of poorly water-soluble drug
WO2008068778A3 (en) Extended release pharmaceutical composition of pramipexole
IL187632A (en) 17-ethynyl-17-hydroxy-13-methyl-7,8,9,11,12,13,14,15,16,17-decahydro-6h-cyclopenta[a]phenantren-3-ylmethyl ester of acetoxy-acetic acid, pharmaceutical dosage unit comprising it and its use for the manufacture of a medicament for contraception
WO2007017146A3 (en) Use of collismycin and derivatives thereof as oxidative stress inhibitors
WO2006136175A3 (en) Pharmaceutical compositions comprising tacrolimus and a cyp3a4 inhibitor
PL2193789T3 (en) The application of 3,5-dihydroxytoluene or derivatives thereof in the preparation of medicine and functional food for treating or preventing depression
WO2007016315A3 (en) Extended release venlafaxine compositions
WO2007052164A8 (en) A pharmaceutical formulation containing olanzapine

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07870545

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 07870545

Country of ref document: EP

Kind code of ref document: A2